SAN DIEGO, June 16, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Chairman and Chief Executive Officer, Robert Stockman, is scheduled to present at the Wells Fargo Securities 2014 Healthcare Conference at 3:00 p.m. US EDT on Wednesday, June 18, 2014. The conference is being held June 17th and 18th at the Intercontinental Hotel in Boston, Massachusetts.
The presentation materials delivered at the conference will be available in the Investor Relations section of REVA's website at www.revamedical.com on the day of the presentation.
About REVA
REVA is a development stage medical device company located in San Diego, California, USA, that is focused on the development, testing, and eventual commercialization of its proprietary bioresorbable stent products, which are also called "scaffolds." The Company's technologies combine its stent designs with its proprietary polymer; these products are designed to offer full x-ray visibility, clinically relevant sizing, and a controlled and safe resorption rate. The Company has several products in clinical study phase. A total of 112 patients were enrolled in its most recent trial in Australia, Brazil, Europe, and New Zealand; they will be followed for a total of five years, with primary data to be obtained at nine and 12 months. REVA will require successful clinical results and regulatory approval before it can commercialize any of its products.